IPVC 2020 Free Live Webinar Series – Register now
To thank the IPVC 2020 participants, faculty, speakers and much of the global HPV community for making the conference a success – IPVS is pleased to offer a series of three one-hour LIVE webinar sessions over the coming weeks to continue in the vein of Science & Education for Action Against HPV. These sessions are FREE of […]
IPVC 2020 Free Live Webinars – Session II: HPV DNA Testing
IPVS is pleased to offer a series of three one-hour LIVE webinar sessions over the coming weeks to continue in the vein of Science & Education for Action Against HPV. These sessions are FREE of charge and open to all who are interested. Session II – 3 Dec 2020 13:00-14:00 CET Current issues for HPV testing […]
IPVC 2020 Free Live Webinars – Session III: Cervical Cancer Elimination – Now, Later or Never
IPVS is pleased to conclude the Post-IPVC 2020 series of free one-hour LIVE webinars in Science & Education for Action Against HPV with the following timely topic: Elimination of Cervical Cancer: Now, Later or Never Session III – 17 Dec 2020 13:00-14:00 CET Speaker: Prof. J. Dillner MD, PhD, Prof of infectious disease epidemiology, […]
IPVS Educational Webinar Series 2021 – Session I: HPV Latency
IPVS is pleased to begin our Educational Webinar Series for 2021 with Session I: HPV Latency: Is it real and does it Matter? 17 February 2021 17:00-18:00 CET Speakers: Dr. Anna-Barbara Moscicki, Professor of Pediatrics, University of California, Los Angeles Prof. John Doorbar, Division of Virology, Department of Pathology, University of Cambridge, UK. Moderator: Prof. […]
European Cancer Organization: Eliminating HPV Cancers in Europe – Next Steps
25 February 2021 14:30-16:30 CET Europe’s new Beating Cancer Plan provides the launchpad for a new effort to eliminate all the cancers caused by HPV across the EU and the wider European region. The European Cancer Organisation’s HPV Action Network is hosting a webinar for the members and stakeholders to discuss how ECO member organisations, […]
IPVS Educational Webinar Series 2021 – The Future of HPV Research
IPVS is pleased to announce the following session of our Educational Webinar Series for 2021 Session II: The Future of HPV Research: Capitalizing on Current Opportunities 22 April 2021 17:00-18:00 CET (Geneva)/ 08:00-09:00 PST (Los Angeles) Moderator: Dr. Elisabeth McClymont, PhD, University of Montreal, Department of Obstetrics & Gynecology Topic: The aim of this session […]
IPVS Regional Webinar 2021: Cervical Cancer Elimination in Asia Pacific
Register today for the IPVS regional webinar in collaboration with the APAC HPV Coalition: Session III: Cervical cancer vaccination & screening in the Asia pacific during the pandemic: Where do we go from here? 15 May 2021 08:00-9:00 CET (Geneva)/ 14:00-15:00 SST (Singapore) Topic: What are the main challenges in cervical cancer screening and prevention […]
IPVS webinar – Your patient is HPV+: what is next?
IPVS webinar – Your patient is HPV+: what is next? Tuesday, 13th July 2021 8:00 EDT (New York) / 14:00 CEST (Geneva) / 20:00 SST (Singapore) Topic: Given the strong evidence that HPV-based screening is more effective than cytology or naked visual inspection after application of acetic acid, more and more countries have switched or […]
IPVS webinar – HPV latency: more questions than answers
IPVS webinar – HPV latency: more questions than answers Wednesday, 29th September 2021 10:00 EDT (New York) / 16:00 CEST (Geneva) Topic: The ability of papillomaviruses to establish infection at human epithelial sites that is largely undetectable by most routine molecular diagnostic tests is indisputable. However, there remains considerable disagreement about what this ‘test negative, […]
34th International Papillomavirus Conference – IPVC 2021
IPVC 2021 – Toronto is Going Virtual! Research & Education for HPV Elimination The 34th International Papillomavirus Conference & Basic Science, Clinical and Public Health Workshops will be held as a virtual conference. This gives certainty that the conference will offer full opportunity for the HPV community to effectively and safely present the latest research […]
